Futura Medical Management

Management criteria checks 2/4

Futura Medical's CEO is James Barder, appointed in Jun 2001, has a tenure of 23.58 years. total yearly compensation is £469.55K, comprised of 59.1% salary and 40.9% bonuses, including company stock and options. directly owns 0.48% of the company’s shares, worth £451.58K. The average tenure of the management team and the board of directors is 10.5 years and 3.3 years respectively.

Key information

James Barder

Chief executive officer

UK£469.6k

Total compensation

CEO salary percentage59.1%
CEO tenure23.6yrs
CEO ownership0.5%
Management average tenure10.5yrs
Board average tenure3.3yrs

Recent management updates

Recent updates

Need To Know: Analysts Are Much More Bullish On Futura Medical plc (LON:FUM)

Sep 13
Need To Know: Analysts Are Much More Bullish On Futura Medical plc (LON:FUM)

We Think Futura Medical (LON:FUM) Can Easily Afford To Drive Business Growth

Apr 17
We Think Futura Medical (LON:FUM) Can Easily Afford To Drive Business Growth

Here's Why We're Not At All Concerned With Futura Medical's (LON:FUM) Cash Burn Situation

Jan 05
Here's Why We're Not At All Concerned With Futura Medical's (LON:FUM) Cash Burn Situation

Is Futura Medical (LON:FUM) In A Good Position To Invest In Growth?

Jul 28
Is Futura Medical (LON:FUM) In A Good Position To Invest In Growth?

We Think Futura Medical (LON:FUM) Needs To Drive Business Growth Carefully

Mar 18
We Think Futura Medical (LON:FUM) Needs To Drive Business Growth Carefully

We're Keeping An Eye On Futura Medical's (LON:FUM) Cash Burn Rate

Sep 25
We're Keeping An Eye On Futura Medical's (LON:FUM) Cash Burn Rate

Here's Why We're Not Too Worried About Futura Medical's (LON:FUM) Cash Burn Situation

May 10
Here's Why We're Not Too Worried About Futura Medical's (LON:FUM) Cash Burn Situation

We're Interested To See How Futura Medical (LON:FUM) Uses Its Cash Hoard To Grow

Jan 10
We're Interested To See How Futura Medical (LON:FUM) Uses Its Cash Hoard To Grow

What We Learned About Futura Medical's (LON:FUM) CEO Compensation

Dec 21
What We Learned About Futura Medical's (LON:FUM) CEO Compensation

CEO Compensation Analysis

How has James Barder's remuneration changed compared to Futura Medical's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-UK£4m

Mar 31 2024n/an/a

-UK£5m

Dec 31 2023UK£470kUK£277k

-UK£7m

Sep 30 2023n/an/a

-UK£6m

Jun 30 2023n/an/a

-UK£5m

Mar 31 2023n/an/a

-UK£5m

Dec 31 2022UK£435kUK£251k

-UK£6m

Sep 30 2022n/an/a

-UK£6m

Jun 30 2022n/an/a

-UK£6m

Mar 31 2022n/an/a

-UK£5m

Dec 31 2021UK£357kUK£243k

-UK£5m

Sep 30 2021n/an/a

-UK£4m

Jun 30 2021n/an/a

-UK£3m

Mar 31 2021n/an/a

-UK£3m

Dec 31 2020UK£309kUK£243k

-UK£2m

Sep 30 2020n/an/a

-UK£4m

Jun 30 2020n/an/a

-UK£6m

Mar 31 2020n/an/a

-UK£7m

Dec 31 2019UK£238kUK£236k

-UK£9m

Sep 30 2019n/an/a

-UK£9m

Jun 30 2019n/an/a

-UK£8m

Mar 31 2019n/an/a

-UK£7m

Dec 31 2018UK£276kUK£230k

-UK£6m

Compensation vs Market: James's total compensation ($USD577.59K) is above average for companies of similar size in the UK market ($USD346.86K).

Compensation vs Earnings: James's compensation has increased whilst the company is unprofitable.


CEO

James Barder (65 yo)

23.6yrs

Tenure

UK£469,554

Compensation

Mr. James Henry Barder has been the Chief Executive Officer of Futura Medical PLC since April 2001. Mr. Barder was first involved with Futura Medical Plc as an investor in 1997. Previously, he served as Ma...


Leadership Team

NamePositionTenureCompensationOwnership
James Barder
CEO & Executive Director23.6yrsUK£469.55k0.48%
£ 451.6k
Angela Hildreth
COO, Finance Director6.9yrsUK£374.79k0.047%
£ 43.9k
Kenneth James
Head of R&D & Executive Director8.2yrsUK£344.00k0.099%
£ 92.0k
William Potter
Chief Scientific Officer & Adviser to the Board12.9yrsUK£14.70kno data
Graham Smith
Head of Alliance Partnerships & Supplyno datano datano data
Kevin Langridge
Head of Qualityno datano datano data

10.5yrs

Average Tenure

68.5yo

Average Age

Experienced Management: FUM's management team is seasoned and experienced (10.5 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
James Barder
CEO & Executive Directorno dataUK£469.55k0.48%
£ 451.6k
Angela Hildreth
COO, Finance Director6.9yrsUK£374.79k0.047%
£ 43.9k
Kenneth James
Head of R&D & Executive Director8.8yrsUK£344.00k0.099%
£ 92.0k
Gordon Davis
Non-Executive Directorless than a yearno datano data
Andrew Unitt
Senior Independent Non-Executive Director3yrsUK£52.00k0.013%
£ 11.8k
Jeffrey Needham
Independent Non-Executive Chairman3.3yrsUK£66.95k0.0092%
£ 8.6k

3.3yrs

Average Tenure

67.5yo

Average Age

Experienced Board: FUM's board of directors are considered experienced (3.3 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/09 21:21
End of Day Share Price 2025/01/09 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Futura Medical plc is covered by 8 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Navid MalikCavendish Historical (Cenkos Securities)
Francesco GregoriEdison Investment Research
Seb JantetPanmure Liberum